Lars Olsson
chairman
management
Wilson Therapeutics
Sweden
Biography
Born 1967. Vice President of Chemistry, Manufacturing and Control (CMC) since 2012. Education: Ph.D., Organic Chemistry, Stockholm University. Other current assignments: Owner of RG Pharma Development. Previous assignments (last five years): Director CMC of Karo Bio AB and QA-associate of Fresenius Kabi AB. Holdings in the Company: 1,000 ordinary shares, 124,000 stock options and 10,000 performance shares LTIP 2017.
Research Interest
Organic Chemistry
